I agree that this site is using cookies. You can find further informations here.
X
Loconsole, Francesco
129  results:
OpenAccess-fulltext X
Search for persons X
?
1

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for m..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10808601/.  , 2024
Link: http://www.ncbi.nlm.nih...
 
?
2

Real-World Experience of Methotrexate in the Treatment of S..:

Damiani, Giovanni ; Amerio, Paolo ; Bardazzi, Federico...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200012/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Brodalumab for the treatment of plaque psoriasis in a real-..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
info:eu-repo/semantics/altIdentifier/pmid/37469659.  , 2023
Link: https://hdl.handle.net/2..
 
?
4

Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise ..:

Stingeni, Luca ; Malara, Giovanna ; Conti, Andrea...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CCID.S378135.  , 2023
Link: https://www.dovepress.co..
 
?
5

Brodalumab for the treatment of plaque psoriasis in a real-..:

Gargiulo, Luigi ; Ibba, Luciano ; Malagoli, Piergiorgio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352451/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise ..:

Stingeni, Luca ; Malara, Giovanna ; Conti, Andrea...
info:eu-repo/semantics/altIdentifier/pmid/36636635.  , 2023
Link: https://hdl.handle.net/1..
 
?
7

Efficacy of Secukinumab in Psoriasis: Post Hoc Gender-Wise ..:

Stingeni, Luca ; Malara, Giovanna ; Conti, Andrea...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829832/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Long-Term Drug Survival and Effectiveness of Secukinumab in..:

Russo, Filomena ; Galluzzo, Marco ; Stingeni, Luca...
info:eu-repo/semantics/altIdentifier/doi/10.2147/CCID.S416149.  , 2023
Link: https://www.dovepress.co..
 
?
9

Understanding Barriers Impacting upon Patient Wellbeing: A ..:

Prignano, Francesca ; Argenziano, Giuseppe ; Bardazzi, Federico...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779771/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Long-Term Drug Survival and Effectiveness of Secukinumab in..:

Russo, Filomena ; Galluzzo, Marco ; Stingeni, Luca...
info:eu-repo/semantics/altIdentifier/pmid/38107670.  , 2023
Link: https://hdl.handle.net/1..
 
?
11

Effectiveness and safety of bimekizumab for the treatment o..:

Gargiulo, Luigi ; Narcisi, Alessandra ; Ibba, Luciano...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442506/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Long-Term Drug Survival and Effectiveness of Secukinumab in..:

Russo, Filomena ; Galluzzo, Marco ; Stingeni, Luca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10725693/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Effectiveness and safety of bimekizumab for the treatment o..:

Gargiulo, Luigi ; Narcisi, Alessandra ; Ibba, Luciano...
info:eu-repo/semantics/altIdentifier/pmid/37614958.  , 2023
Link: https://hdl.handle.net/1..
 
?
14

Real-world outcomes in patients with moderate-to-severe pla..:

Galluzzo, Marco ; Talamonti, Marina ; Bernardini, Nicoletta...
info:eu-repo/semantics/altIdentifier/pmid/35708257.  , 2022
Link: https://hdl.handle.net/1..
 
?
15

Real‐life effectiveness of tildrakizumab in chronic plaque ..:

Narcisi, Alessandra ; Valenti, Mario ; Gargiulo, Luigi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092064/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15